Quantifying the Size of Holes Antibacterial Compounds Create in Cell Walls
By LabMedica International staff writers Posted on 23 Jan 2013 |

Image: Transmission electron microscopy image of a Streptococcus pyogenes cell experiencing lysis after exposure to the highly active enzyme PlyC (Photo courtesy of Daniel Nelson, UMD).
The emergence of antibiotic-resistant bacteria has initiated a search for alternatives to traditional antibiotics. One potential option is PlyC, a powerful enzyme that kills the bacteria that causes streptococcal toxic shock syndrome and strep throat. PlyC functions by fastening onto the surface of a bacteria cell and chomping a hole in the cell wall large enough for the bacteria’s inner membrane to protrude from the cell, eventually causing the cell to burst and die.
Research has shown that unconventional antimicrobials such as PlyC can effectively kill bacteria. However, essential questions remain about how bacteria respond to the holes that these therapeutics make in their cell wall and what size holes bacteria can withstand before degrading. Solving those problems could improve the efficacy of current antibacterial drugs and begin to develop new ones.
Researchers from the Georgia Institute of Technology (Atlanta, USA) and the University of Maryland (College Park, USA) recently conducted a study to try to answer those questions. The researchers created a biophysical model of the response of a Gram-positive bacterium to the formation of a hole in its cell wall. Then they used experimental measurements to validate the theory, which predicted that a hole in the bacteria cell wall larger than 15–24 nm in diameter would cause the cell to lyse, or burst. These small holes are approximately one-hundredth the diameter of a typical bacterial cell.
“Our model correctly predicted that the membrane and cell contents of Gram-positive bacteria cells explode out of holes in cell walls that exceed a few dozen nanometers. This critical hole size, validated by experiments, is much larger than the holes Gram-positive bacteria use to transport molecules necessary for their survival, which have been estimated to be less than 7 nanometers in diameter,” said Dr. Joshua Weitz, an associate professor in the School of Biology at Georgia Tech.
The study’s findings were published online on January 9, 2013, in the Journal of the Royal Society Interface. Common Gram-positive bacteria that infect humans include Streptococcus, which causes strep throat; Staphylococcus, which causes impetigo; and Clostridium, which causes botulism and tetanus. Gram-negative bacteria include Escherichia, which causes urinary tract infections; Vibrio, which causes cholera; and Neisseria, which causes gonorrhea.
Gram-positive bacteria are different from Gram-negative bacteria in the structure of their cell walls. The cell wall comprises the outer layer of Gram-positive bacteria, whereas the cell wall lies between the inner and outer membrane of Gram-negative bacteria and is therefore protected from direct exposure to the environment.
Georgia Tech biology graduate student Gabriel Mitchell, Georgia Tech physics professor Dr. Kurt Wiesenfeld, and Dr. Weitz developed a biophysical theory of the response of a Gram-positive bacterium to the formation of a hole in its cell wall. The model detailed the effect of pressure, stretching and bending forces on the altering configuration of the cell membrane due to a hole. The force associated with bending and stretching pulls the membrane inward, while the pressure from the inside of the cell pushes the membrane outward through the hole.
“We found that bending forces act to keep the membrane together and push it back inside, but a sufficiently large hole enables the bending forces to be overpowered by the internal pressure forces and the membrane begins to escape out and the cell contents follow,” said Dr. Weitz.
The balance between the bending and pressure forces led to the model prediction that holes 15–24 nm in diameter or larger would cause a bacteria cell to burst. To assess the hypothesis, Dr. Daniel Nelson, an assistant professor at the University of Maryland, utilized transmission electron microscopy images to gauge the size of holes created in lysed Streptococcus pyogenes bacteria cells following PlyC exposure.
Dr. Nelson discovered holes in the lysed bacteria cells that ranged in diameter from 22–180 nm, with a mean diameter of 68 nm. These experimental measurements agreed with the researchers’ theoretic calculation of hole sizes that cause bacterial cell death. According to the researchers, their theoretic model is the first to consider the effects of cell wall thickness on lysis. “Because lysis events occur most often at thinner points in the cell wall, cell wall thickness may play a role in suppressing lysis by serving as a buffer against the formation of large holes,” said Mr. Mitchell.
The combination of research and theory used in this study provided clues into the effect of defects on a cell’s viability and the processes employed by enzymes to interrupt homeostasis and cause bacteria cell death. To additionally determine the processes behind enzyme-induced lysis, the researchers plan to measure membrane dynamics as a function of hole geometry in the future.
Related Links:
Georgia Institute of Technology
University of Maryland
Research has shown that unconventional antimicrobials such as PlyC can effectively kill bacteria. However, essential questions remain about how bacteria respond to the holes that these therapeutics make in their cell wall and what size holes bacteria can withstand before degrading. Solving those problems could improve the efficacy of current antibacterial drugs and begin to develop new ones.
Researchers from the Georgia Institute of Technology (Atlanta, USA) and the University of Maryland (College Park, USA) recently conducted a study to try to answer those questions. The researchers created a biophysical model of the response of a Gram-positive bacterium to the formation of a hole in its cell wall. Then they used experimental measurements to validate the theory, which predicted that a hole in the bacteria cell wall larger than 15–24 nm in diameter would cause the cell to lyse, or burst. These small holes are approximately one-hundredth the diameter of a typical bacterial cell.
“Our model correctly predicted that the membrane and cell contents of Gram-positive bacteria cells explode out of holes in cell walls that exceed a few dozen nanometers. This critical hole size, validated by experiments, is much larger than the holes Gram-positive bacteria use to transport molecules necessary for their survival, which have been estimated to be less than 7 nanometers in diameter,” said Dr. Joshua Weitz, an associate professor in the School of Biology at Georgia Tech.
The study’s findings were published online on January 9, 2013, in the Journal of the Royal Society Interface. Common Gram-positive bacteria that infect humans include Streptococcus, which causes strep throat; Staphylococcus, which causes impetigo; and Clostridium, which causes botulism and tetanus. Gram-negative bacteria include Escherichia, which causes urinary tract infections; Vibrio, which causes cholera; and Neisseria, which causes gonorrhea.
Gram-positive bacteria are different from Gram-negative bacteria in the structure of their cell walls. The cell wall comprises the outer layer of Gram-positive bacteria, whereas the cell wall lies between the inner and outer membrane of Gram-negative bacteria and is therefore protected from direct exposure to the environment.
Georgia Tech biology graduate student Gabriel Mitchell, Georgia Tech physics professor Dr. Kurt Wiesenfeld, and Dr. Weitz developed a biophysical theory of the response of a Gram-positive bacterium to the formation of a hole in its cell wall. The model detailed the effect of pressure, stretching and bending forces on the altering configuration of the cell membrane due to a hole. The force associated with bending and stretching pulls the membrane inward, while the pressure from the inside of the cell pushes the membrane outward through the hole.
“We found that bending forces act to keep the membrane together and push it back inside, but a sufficiently large hole enables the bending forces to be overpowered by the internal pressure forces and the membrane begins to escape out and the cell contents follow,” said Dr. Weitz.
The balance between the bending and pressure forces led to the model prediction that holes 15–24 nm in diameter or larger would cause a bacteria cell to burst. To assess the hypothesis, Dr. Daniel Nelson, an assistant professor at the University of Maryland, utilized transmission electron microscopy images to gauge the size of holes created in lysed Streptococcus pyogenes bacteria cells following PlyC exposure.
Dr. Nelson discovered holes in the lysed bacteria cells that ranged in diameter from 22–180 nm, with a mean diameter of 68 nm. These experimental measurements agreed with the researchers’ theoretic calculation of hole sizes that cause bacterial cell death. According to the researchers, their theoretic model is the first to consider the effects of cell wall thickness on lysis. “Because lysis events occur most often at thinner points in the cell wall, cell wall thickness may play a role in suppressing lysis by serving as a buffer against the formation of large holes,” said Mr. Mitchell.
The combination of research and theory used in this study provided clues into the effect of defects on a cell’s viability and the processes employed by enzymes to interrupt homeostasis and cause bacteria cell death. To additionally determine the processes behind enzyme-induced lysis, the researchers plan to measure membrane dynamics as a function of hole geometry in the future.
Related Links:
Georgia Institute of Technology
University of Maryland
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more